Helmet branding partnership with INDYCAR’s reigning development champion places Sports.com on the global motorsport stageINDIANAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- Sports.com, a member of the Lottery.com Inc. family of brands (Nasdaq LTRY;LTRYW) (“Lottery.com”’or “the Company”), the fast-growing platform at the intersection of sports, media and technology, proudly announces a high-visibility partnership with Louis Foster, one of the brightest young drivers in motorsport, ahead of his debut in the 2025 I ...

CXApp (CXAI) Q1 2025 Earnings Call May 20, 2025 05:00 PM ET Company Participants Khurram Sheikh - Founder, Chairman & CEOJoy Mbanugo - Chief Financial Officer Operator Greetings. Welcome to the CX App First Quarter twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. Please note, to ask a question, please click on the Ask Question button on the left side of your player. Type in your question and hit send. Please note, this conference is being recorded. I will now turn ...

Sports.com at Soccerex Amsterdam L to R: Marc Bircham, Tamer Hassan, and Patrick McCreanor, Soccerex FORT WORTH, Texas, May 20, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (NASDAQ: LTRY, LTRYW) (“Lottery.com” or the “Company”), a leading technology company transforming the intersection of gaming, sports and entertainment, is proud to announce its role as Title Sponsor of Soccerex Europe 2025, taking place from May 19–21 at the iconic Johan Cruyff Arena in Amsterdam. As headline sponsor of this globally re ...

OPKO Health (OPK) FY 2025 Conference May 20, 2025 09:00 AM ET Speaker0 H. C. Wainwright's Third Annual Bioconector Investor Conference at NASDAQ. My name is Yi Chen. I'm an equity research analyst at H. C. Wainwright. For this session, we are delighted to have Mr. Elias Zahoni, president and vice chairman of OpcoHealth, and mister Evan Logo, senior vice president and chief financial officer of Opco join us for our fight Fireside Chat. Thank you for joining. Speaker1 Well, thank you for having us. Speaker0 T ...

Core Insights - EngageLab has launched two new features, Smart Push and Push Plan, aimed at enhancing user engagement and marketing efficiency for global e-commerce businesses, with early adopters reporting over 30% increases in click-through rates [1][2][9] Feature Summaries Smart Push - Smart Push predicts the optimal time for delivering push notifications based on users' activity patterns, ensuring messages arrive at their personal "golden moment" [3][9] - This feature is available for a limited-time free trial via the EngageLab dashboard [5] Push Plan - Push Plan provides a centralized command center for managing complex promotional campaigns, allowing for multi-wave, multi-segment, and multi-content strategies [7][10] - It offers holistic performance insights, tracking key metrics like delivery rate, click rate, and conversions across the entire campaign lifecycle [10] Advantages of New Features - Higher click-through rates and increased conversion efficiency are reported due to delivering messages when users are most active [9] - Enhanced user experience by avoiding interruptions and fostering positive brand perception [9] - Flexibility in operations with full support via API and Web Portal for easy task management and strategy optimization [10] Company Overview - EngageLab is a leading AI-powered omnichannel customer engagement solution provider, supporting businesses in over 220 countries and regions, delivering more than 1 million messages every second [12]

24Social Introduces Tools to Drive Organic Engagement on Social Media Platforms Like Facebook and TikTok24Social, a leader in ethical social media engagement, launches tools to boost organic growth and visibility on platforms like Facebook and TikTok. These tools help businesses drive real interactions, follow platform guidelines, and avoid fake engagement or misleading tactics for sustainable digital success.May 15, 2025 3:06 AM EDT | Source: PlentisoftBangkok, Thailand--(Newsfile Corp. - May ...

Summary of Chimera's Conference Call Company Overview - **Company**: Chimera - **Industry**: Biopharmaceuticals, specifically focused on clinical stage drug development Key Points and Arguments FDA Interactions - Chimera has ongoing interactions with the FDA and other agencies, with no material changes observed in recent months [5][9] Manufacturing Plans - Current manufacturing is global, with a commitment to source commercial materials in the U.S. when possible [6][7] - The CEO highlighted a lack of infrastructure in the U.S. to support the biopharma industry, indicating a need for investment in basic research and infrastructure [8][9] Upcoming Catalysts - Healthy volunteer data for KT621 is expected in June, with a focus on presenting comprehensive data rather than piecemeal [14][15] - The STAT6 program is highlighted as unique, with potential to replicate the effects of existing blockbuster drugs like dupilumab [15][16] Biomarker Strategy - The primary biomarker for the STAT6 program is the degradation of STAT6 itself, which allows for direct measurement of target engagement [19][21] - Comparison with dupilumab's effects on biomarkers like TARC is discussed, with caution against drawing direct conclusions due to different study designs [20][21] Phase Ib Study - A Phase Ib study for atopic dermatitis (AD) patients has already begun, with expectations for robust biomarker changes and clinical endpoints by Q4 [25][26][48][49] Safety Profile - Previous studies indicated a good safety profile for related compounds, with no specific concerns for STAT6 degradation noted [34][36] - The CEO mentioned a subclinical QT effect observed in earlier studies, but no expectation of similar issues for the current drug [39][40] Competitive Landscape - The only oral approved drug for AD is a JAK inhibitor, which has safety concerns. Chimera's STAT6 degrader is positioned as a Th2-specific treatment [40][41] - The CEO expressed confidence in the differentiation of their product based on its mechanism of action [41][42] Future Development Plans - Chimera plans to develop the STAT6 drug across multiple indications, similar to dupilumab, with a focus on aggressive development strategies [63][64] - The company has a strong cash position of $775 million, expected to last until the first half of 2028, covering multiple data readouts [68][69] Additional Important Information - The CEO emphasized the importance of achieving over 90% STAT6 degradation for robust efficacy in clinical studies [28][31] - The company is prepared with multiple molecules in its pipeline, ensuring flexibility in case of underperformance in current studies [62][63] This summary encapsulates the key insights from Chimera's conference call, highlighting the company's strategic direction, upcoming milestones, and competitive positioning within the biopharmaceutical industry.

Core Insights - Biodesix, Inc. has been recognized as a Colorado Top Workplaces 2025 Winner, highlighting its commitment to a people-first organizational culture [1] - This recognition is based on employee feedback collected through a third-party survey conducted by Energage, which measures various aspects of the employee experience [2] - This marks the second consecutive year that Biodesix has received such recognition, following the Inc. Magazine 2024 Best Workplaces award [3] Company Overview - Biodesix is a leading diagnostic solutions company focused on improving clinical care and outcomes for patients, particularly those with lung disease [4] - The company offers diagnostic tests that support clinical decisions and expedite personalized care, as well as development services for biopharmaceutical and life sciences companies [4] Employee Engagement - The Top Workplaces award is based on themes such as respect, support, growth opportunities, and empowerment within the workplace [2][4] - The CEO of Biodesix emphasized the importance of employee contributions to the company's high-performing culture and commitment to excellence [3] About Energage - Energage is a company that specializes in turning employee feedback into actionable business intelligence and employer recognition through the Top Workplaces program [5] - The organization has a rich history of culture research, having surveyed over 27 million employees across more than 70,000 organizations [5]

Owens Corning (OC) 2025 Investor Day May 14, 2025 09:00 AM ET Speaker0 Hello everyone. Welcome to the twenty twenty five Owens Corning Investor Day. I'm Amber Wolfarth, Vice President of Corporate Affairs and Investor Relations here at Owens Corning. And on behalf of our entire company, we want to thank you for taking the time to join us today. For those of you joining us virtually, thank you for tuning in and we're so glad you're here. For those of you here in the room in Toledo, welcome to our headquarter ...

Core Insights - Brera Holdings PLC has signed a letter of intent to launch the PLAY LEAP digital fan engagement platform in partnership with Leap Sport Digital Ltd., starting with its Italian Serie B club, S.S. Juve Stabia [2][3] - The initiative aims to modernize the fan experience by allowing fans to engage through daily challenges, video uploads, and voting on content, creating a gamified digital ecosystem [3][4] - The PLAY LEAP platform is designed as a Software-as-a-Service (SaaS) solution, focusing on monetization through usage, brand activations, and fan insights [4][6] Company Strategy - The integration of PLAY LEAP is part of Brera Holdings' strategy to enhance fan engagement and create scalable, recurring digital revenue [4][5] - The platform targets Gen Z and Alpha fans, emphasizing interactivity and creativity in sports experiences [5] - Brera Holdings plans to expand the platform across multiple clubs in its international portfolio following the initial launch with Juve Stabia [5] Revenue Model - The revenue model includes active user tiers where clubs pay only for engaged fans, ensuring alignment of ROI with community growth [6] - In-app sponsorships will provide custom-branded challenges and premium inventory for sponsors [6] - Real-time analytics will enable clubs to optimize fan marketing and unlock new partner value [6] Company Background - Brera Holdings is focused on expanding its portfolio of emerging football and sports clubs, building on the legacy of Brera FC [7] - The company has made strategic acquisitions and investments, including a 90% stake in Fudbalski Klub Akademija Pandev and a majority stake in UYBA Volley [8] - As of February 12, 2025, Brera holds a 38.46% equity interest in Juve Stabia, marking a significant expansion of its business model [9]